Host Mike Moore recently interviewed Acarix CEO, Aamir Mahmood.  The company's CADScor®System is an advanced acoustic-based diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care.  As pointed out in this discussion, a number of clinical & economic value propositions exist for this technology, which will ultimately contribute to rapid adoption across multiple centers of care, starting with the Emergency Room.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health